Glaxosmithkline's Marketing Strategy for Requip: A Case Study in Product Lifecycle Management

<< Previous

Excerpts Contd...

GSK's marketing efforts were widely appreciated by marketing experts, doctors and patient advocacy groups. Experts were particularly impressed by GSK's initial un-branded ad campaigns that strove to increase awareness about the disease. Some doctors and patient advocates praised GSK for raising the profile of a disorder, which they considered under-diagnosed and under-treated. They said that GSK had helped educate the doctors and consumers about this relatively unknown disorder...

The campaign for Requip also earned GSK a lot of negative attention. Critics said that GSK had created a market for RLS by aggressively marketing the disease through sales force visits to doctors, advertisements in medical magazine, and DTC advertising. The company was accused of disease mongering and critics also contended that there were many conflicts of interest in GSK's marketing of Requip in RLS.

Disease Mongering Critics said that pharmaceutical companies such as GSK were inventing new diseases in the quest for profits, a practice they called disease mongering. They accused the industry of creating a number of newly-defined medical conditions such as RLS, sexual dysfunction, erectile dysfunction, sleeplessness, social anxiety disorder, irritable bowel syndrome, etc., to keep their revenues moving northward... Conflict of Interest Some critics contended that GSK was expanding the market for its drugs with the help of patient advocacy groups. In addition to the incident involving ESG in the UK, GSK had attracted criticism for using RLSF to allegedly forward its marketing agenda...

Criticism of DTC advertising
Some experts believed that disease mongering was more of a problem in the US as DTC advertising was allowed. Critics contended that such ads exploited the consumers' health fears...

GSK defended its marketing of Requip. The company contended that it viewed sharing medical information on diseases, including RLS, as a part of its mission. GSK said that people should not trivialize RLS as it was a real medical condition that afflicted a number of patients around the world...

Exhibit I: GSK's Logo
Exhibit II: GSK's Five-Year Financial Summary
Exhibit III: Pack-Shot of Requip
Exhibit IV: A Brief Note on Restless Legs Syndrome
Exhibit V: A Requip Ad for PD
Exhibit VI: An Un-Branded RLs Print Ad
Exhibit VII: Screen-Shot of Restlesslegs.com
Exhibit VIII: Screen-Shot of Requip.com
Exhibit IX: Global RLS R&D Pipeline
Exhibit X: How Media Helped Requip to become a Treatment for RLs

---

Custom Search

Fundamentals of Marketing Management Textbooks Collection	Fundamentals of Marketing Management Workbook Workbooks Collection	Case Studies in Marketing - Vol. II Case Study Volumes Collection